Amendments to the Devices Law on “Misleading or Unsubstantiated Claims” have been enacted by the MHRA following a lengthy investigation by the NIHR Biomedical Research Centre: Birmingham Diagnostic team. The amendment will remove tests from the market that mislead users regarding intended use, safety, or performance; when supporting evidence is inadequate or when it fails to inform of significant risk,…
Ben KempMay 26, 2026


